Cavanna, L.; Proietto, M.; Citterio, C.; Anselmi, E.; Zaffignani, E.; Stroppa, E.M.; Borsotti, M.T.; Contini, A.; Di Girolamo, G.; Quitadamo, V.M.;
et al. COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety. Vaccines 2022, 10, 164.
https://doi.org/10.3390/vaccines10020164
AMA Style
Cavanna L, Proietto M, Citterio C, Anselmi E, Zaffignani E, Stroppa EM, Borsotti MT, Contini A, Di Girolamo G, Quitadamo VM,
et al. COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety. Vaccines. 2022; 10(2):164.
https://doi.org/10.3390/vaccines10020164
Chicago/Turabian Style
Cavanna, Luigi, Manuela Proietto, Chiara Citterio, Elisa Anselmi, Elena Zaffignani, Elisa Maria Stroppa, Maria Teresa Borsotti, Andrea Contini, Gabriella Di Girolamo, Vincenzo Matteo Quitadamo,
and et al. 2022. "COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety" Vaccines 10, no. 2: 164.
https://doi.org/10.3390/vaccines10020164
APA Style
Cavanna, L., Proietto, M., Citterio, C., Anselmi, E., Zaffignani, E., Stroppa, E. M., Borsotti, M. T., Contini, A., Di Girolamo, G., Quitadamo, V. M., Bacchetta, N., Muroni, M., Brescia, M. G., & Delledonne, M.
(2022). COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety. Vaccines, 10(2), 164.
https://doi.org/10.3390/vaccines10020164
